pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 1
LS-01
Esophageal Squamous Cell Carcinoma (ESCC)
Guangzhou Liushun Biotechnology Co Ltd
0 catalysts
Phase 1
LSLBP-002
Renal Cell Carcinoma
Shanghai Lishan Biopharmaceuticals Co Ltd
0 catalysts
Preclinical
LTI-214
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Leukogene Therapeutics Inc
0 catalysts
Phase 1
← prev
page 26 of 62
next →
131
Pain89
Neurology1
LTZ-301
Diffuse Large B-Cell Lymphoma
LTZ Therapeutics Inc
0 catalysts
Phase 2
LXP-109
Non-Small Cell Lung Cancer
LaunXP Biomedical Co Ltd
0 catalysts
Phase 2
LXP-5268
Triple-Negative Breast Cancer (TNBC)
LaunXP Biomedical Co Ltd
0 catalysts
Phase 1
LYL-273
Metastatic Colorectal Cancer
$LYELLyell Immunopharma, Inc.
0 catalysts
Phase 2
LYT-200
Liver Cancer
Gallop Oncology Inc
0 catalysts
Phase 1
LZ-001
Non-Small Cell Lung Cancer
Livzon Pharmaceutical Group Inc
0 catalysts
Phase 2
M-032
Anaplastic Astrocytoma
UAB Minority Health and Health Equity Research Center
0 catalysts
Preclinical
MAb AR9.6
Pancreatic Cancer
OncoCare Therapeutics Inc
0 catalysts
Phase 1
MB-101
Brain Tumor
$MBIOMUSTANG BIO, INC.
0 catalysts
Phase 2
MB-105
Cutaneous T-Cell Lymphoma
March Biosciences
0 catalysts
Phase 1
MB-108
Anaplastic Astrocytoma
$MBIOMUSTANG BIO, INC.
0 catalysts
Preclinical
MB-204
Alzheimer's Disease
Marvel Biotechnology Inc
0 catalysts
Phase 1
MBQ-167
Triple-Negative Breast Cancer (TNBC)
MBQ Pharma Inc
0 catalysts
Phase 2
MC-001
Spinal Cord Injury
StemCyte Inc
0 catalysts
Phase 1
MCLA-145
Solid Tumor
Merus NV
0 catalysts
Phase 1
MCM-998
Multiple Myeloma (Kahler Disease)
$NVSNOVARTIS AG
0 catalysts
Phase 2
MDNA-11
Solid Tumor
$MDNAFMedicenna Therapeutics Corp.
0 catalysts
Phase 2
MDX-1097
Refractory Multiple Myeloma
HaemaLogix Pty Ltd
0 catalysts
Phase 2
MEDI-0457
Oropharyngeal Cancer
$AZNASTRAZENECA PLC
0 catalysts
Phase 1
MEM-288
Cutaneous Squamous Cell Carcinoma (cSCC)
Memgen Inc
0 catalysts
Phase 1
MEN-2312
Hematological Tumor
Stemline Therapeutics Inc
0 catalysts
Phase 1
MEN-2501
Fallopian Tube Cancer
Stemline Therapeutics Inc
0 catalysts
Preclinical
MER-101
Ewing Sarcoma
MERLIN Biotech LLC
0 catalysts
Phase 1
MGC-028
Bile Duct Cancer (Cholangiocarcinoma)
$MGNXMACROGENICS INC
0 catalysts
Preclinical
MGC-030
Solid Tumor
$MGNXMACROGENICS INC
0 catalysts
Phase 1
MGD-024
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
$MGNXMACROGENICS INC
0 catalysts
Preclinical
MIGRA-NP01
Pancreatic Cancer
Migra-Therapeutics LLC
0 catalysts